Nicholas Corcoran insider trades: TransMedics Group (TMDX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Nicholas reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | TMDX | ↓ Sell | 2,966 | $139.12 | $413K | Direct | Mar 4, 2026 (2d) |
| Aug 27, 2024 | TMDX | ↓ Sell | 10,000 | $176.02 | $1.8M | Direct | Aug 29, 2024 (2d) |
| May 6, 2024 | TMDX | ↓ Sell | 3,222 | $129.91 | $419K | Direct | May 8, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other TMDX insiders
Open-market trades in the last 12 months
About Nicholas Corcoran's insider trades
Nicholas Corcoran is See remarks at TransMedics Group (TMDX). Since May 6, 2024, Nicholas has reported no open-market purchases and 3 sales worth $2.6M on SEC Form 4. In the last 12 months: 1 sale ($413K).
Their filings also include grants and awards (4 filings), shares withheld for taxes (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TMDX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.